Hims & Hers Health (HIMS) Goodwill & Intangibles (2020 - 2026)
Hims & Hers Health (HIMS) reported Goodwill & Intangibles of $603.9 million for Q1 2026, up 274.65% on a YoY basis from $161.2 million in Q1 2025, and up 27.28% sequentially from $474.4 million in Q4 2025.
Hims & Hers Health (HIMS) Goodwill & Intangibles (2020 - 2026) Analysis & Trends
Hims & Hers Health (HIMS) has 7 years of Goodwill & Intangibles data on file, last reported at $603.9 million in Q1 2026.
- For the quarter ending Q1 2026, Goodwill & Intangibles rose 274.65% year-over-year to $603.9 million; the trailing twelve-month figure through Mar 2026 stood at $603.9 million (up 274.65% YoY), and the FY2025 full-year result was $474.4 million, up 203.86% from the prior year.
- Goodwill & Intangibles grew to $603.9 million in Q1 2026, from $474.4 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $603.9 million in Q1 2026 to a low of $46.7 million in Q3 2024.
- A 5-year average of $198.2 million and a median of $133.0 million in 2022 frame the typical range for Goodwill & Intangibles.
- Across the five-year window, Goodwill & Intangibles soared 4817.38% in 2022 and tumbled 64.15% in 2024, its largest moves.
- Tracing HIMS's Goodwill & Intangibles over 5 years: stood at $132.7 million in 2022, then dropped by 2.46% to $129.5 million in 2023, then grew by 20.61% to $156.1 million in 2024, then surged by 203.86% to $474.4 million in 2025, then grew by 27.28% to $603.9 million in 2026.
- Business Quant data shows HIMS's Goodwill & Intangibles at $603.9 million in Q1 2026, $474.4 million in Q4 2025, and $454.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn |
| 10 | Hims & Hers Health | 6.44 Bn | 5.69 Bn | 396.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 603.87 Mn |
| Dec 31, 2025 | 474.44 Mn |
| Sep 30, 2025 | 454.17 Mn |
| Jun 30, 2025 | 158.41 Mn |
| Mar 31, 2025 | 161.18 Mn |
| Dec 31, 2024 | 156.14 Mn |
| Sep 30, 2024 | 46.67 Mn |
| Jun 30, 2024 | 128.01 Mn |
| Mar 31, 2024 | 128.74 Mn |
| Dec 31, 2023 | 129.46 Mn |
| Sep 30, 2023 | 130.18 Mn |
| Jun 30, 2023 | 130.84 Mn |
| Mar 31, 2023 | 131.79 Mn |
| Dec 31, 2022 | 132.72 Mn |
| Sep 30, 2022 | 132.97 Mn |
| Jun 30, 2022 | 134.69 Mn |
| Mar 31, 2022 | 135.73 Mn |
| Dec 31, 2021 | 136.77 Mn |
| Sep 30, 2021 | 137.81 Mn |
| Jun 30, 2021 | 2.74 Mn |